MedTrace Logo

Divalproex vs. Lamotrigine for Bipolar Disorder

NCT00451542 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2017-04-27

No results posted yet for this study

Summary

This study is a retrospective chart review of patients treated for bipolar disorder at the TVAMC in the past four years cross-referenced with the electronic pharmacy file for having received a prescription of divalproex or lamotrigine.

Conditions

Sponsors & Collaborators

  • Tuscaloosa Research & Education Advancement Corporation

    lead OTHER

Principal Investigators

  • Lori L Davis, MD · Tuscaloosa Reseach and Education Advancement Corporation

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-01
Primary Completion
2007-05-01
Completion
2008-02-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00451542 on ClinicalTrials.gov